TY  - CHAP
AU  - Pedro A. López-Saura
AU  - Jorge Berlanga-Acosta
AU  - José I. Fernández-Montequín
AU  - Carmen Valenzuela-Silva
AU  - Odalys González-Díaz
AU  - William Savigne
AU  - Lourdes Morejon-Vega
AU  - Amaurys del Río-Martín
AU  - Luis Herrera-Martínez
AU  - Ernesto López-Mola
AU  - Boris Acevedo-Castro
ED  - Thanh Dinh
Y1  - 2011-12-09
PY  - 2011
T1  - Intralesional Human Recombinant Epidermal Growth Factor for the Treatment of Advanced Diabetic Foot Ulcer: From Proof of Concept to Confirmation of the Efficacy and Safety of the Procedure
N2  - Over the last decade, it is becoming increasingly clear that diabetes mellitus is a global epidemic.  The influence of diabetes is most readily apparent in its manifestation in foot complications across cultures and continents.  In this unique collaboration of global specialists, we examine the explosion of foot disease in locations that must quickly grapple with both mobilizing medical expertise and shaping public policy to best prevent and treat these serious complications.
In other areas of the world where diabetic foot complications have unfortunately been all too common, diagnostic testing and advanced treatments have been developed in response. The bulk of this book is devoted to examining the newest developments in basic and clinical research on the diabetic foot.  It is hoped that as our understanding of the pathophysiologic process expands, the devastating impact of diabetic foot complications can be minimized on a global scale.
BT  - Global Perspective on Diabetic Foot Ulcerations
SP  - Ch. 12
UR  - https://doi.org/10.5772/28150
DO  - 10.5772/28150
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -